HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix

Gynecologic Oncology

Volumn 128, Issue 3, 2013, Pages 530-534

  Baalbergen, Astrid ^a   Smedts, Frank ^a   Ewing, Patricia ^b   Snijders, Peter J F ^c   Meijer, Chris J L M ^c   Helmerhorst, Theo J M ^b  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adenocarcinoma cervix uteri; Human papillomavirus; Survival

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL EVALUATION; DISEASE FREE SURVIVAL; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NETHERLANDS; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; TUMOR LOCALIZATION; UTERINE CERVIX CARCINOMA; VIRUS TYPING;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84873742915     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.12.013     Document Type: Article

References (33)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. A.P. Vizcaino, V. Moreno, F.X. Bosch, N. Munoz, X.M. Barros-Dios, and D.M. Parkin International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas Int J Cancer 75 1998 536 545
3. F. Bray, B. Carstensen, H. Moller, M. Zappa, M.P. Zakelj, and G. Lawrence Incidence trends of adenocarcinoma of the cervix in 13 European countries Cancer Epidemiol Biomarkers Prev 14 2005 2191 2199
4. S. Bulk, O. Visser, L. Rozendaal, R.H. Verheijen, and C.J. Meijer Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area Br J Cancer 89 2003 834 839
5. R. Hale, H. Fox, and C.H. Buckley Classification of cervical carcinoma Histopathology 18 1991 287
6. W. Kinney, G.F. Sawaya, H.Y. Sung, K.A. Kearney, M. Miller, and R.A. Hiatt Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening Acta Cytol 47 2003 167 171
7. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
8. X. Castellsague, M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, and S. Franceschi Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention J Natl Cancer Inst 98 2006 303 315
9. N. Li, S. Franceschi, R. Howell-Jones, P.J. Snijders, and G.M. Clifford Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication Int J Cancer 128 2011 927 935
10. G. Clifford, and S. Franceschi Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix Int J Cancer 122 2008 1684 1685
11. G. Ronco, P. Giorgi-Rossi, F. Carozzi, M. Confortini, P. Dalla Palma, and A. Del Mistro Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Lancet Oncol 11 2010 249 257
12. N.W. Bulkmans, J. Berkhof, L. Rozendaal, F.J. van Kemenade, A.J. Boeke, and S. Bulk Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 2007 1764 1772
13. A.M. de Roda Husman, J.M. Walboomers, C.J. Meijer, E.K. Risse, M.E. Schipper, and T.M. Helmerhorst Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction Int J Cancer 56 1994 802 806
14. A.J. van den Brule, R. Pol, N. Fransen-Daalmeijer, L.M. Schouls, C.J. Meijer, and P.J. Snijders GP5 +/6 + PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes J Clin Microbiol 40 2002 779 787
15. M. Odida, B. Lloveras, N. Guimera, and E. Weiderpass The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix BMC Res Notes 3 2010 54
16. K.D. Quint, M.N. de Koning, L.J. van Doorn, W.G. Quint, and E.C. Pirog HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix Gynecol Oncol 117 2010 297 301
17. Chepovetsky J, Kalir T, Weiderpass E. Clinical applicability of microarray technology in the diagnosis, prognostic stratification, treatment and clinical surveillance of cervical adenocarcinoma. Curr Pharm Des in press, (Electronic publication ahead of print, sept 24).
18. E.C. Pirog, B. Kleter, S. Olgac, P. Bobkiewicz, J. Lindeman, and W.G. Quint Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma Am J Pathol 157 2000 1055 1062
19. O. Houghton, J. Jamison, R. Wilson, J. Carson, and W.G. McCluggage p16 immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection Histopathology 57 2010 342 350
20. M. Kocken, A. Baalbergen, P.J. Snijders, J. Bulten, W.G. Quint, and F. Smedts High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix Gynecol Oncol 122 2011 297 302
21. S. Bulk, J. Berkhof, N.W. Bulkmans, G.D. Zielinski, L. Rozendaal, and F.J. van Kemenade Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands Br J Cancer 94 2006 171 175
22. M. Seoud, W.A. Tjalma, and V. Ronsse Cervical adenocarcinoma: moving towards better prevention Vaccine 29 2011 9148 9158
23. M.M. Dabic, M. Nola, I. Tomicic, S. Dotlic, M. Petrovecki, and S. Jukic Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection Acta Obstet Gynecol Scand 87 2008 366 372
24. R.P. Insinga, K.L. Liaw, L.G. Johnson, and M.M. Madeleine A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States Cancer Epidemiol Biomarkers Prev 17 2008 1611 1622
25. M.L. Tornesello, S. Losito, G. Benincasa, F. Fulciniti, G. Botti, and S. Greggi Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix Gynecol Oncol 121 2011 32 42
26. S. Andersson, E. Rylander, B. Larsson, A. Strand, C. Silfversvard, and E. Wilander The role of human papillomavirus in cervical adenocarcinoma carcinogenesis Eur J Cancer 37 2001 246 250
27. W.A. Tjalma, A. Fiander, O. Reich, N. Powell, A.M. Nowakowski, and B. Kirschner Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe Int J Cancer 132 2013 854 867
28. C.H. Lai, C.J. Chang, H.J. Huang, S. Hsueh, A. Chao, and J.E. Yang Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery J Clin Oncol 25 2007 3628 3634
29. W.D. Kang, C.H. Kim, M.K. Cho, J.W. Kim, H.Y. Cho, and Y.H. Kim HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy Gynecol Oncol 121 2011 546 550
30. J.Y. Kim, B.H. Nam, and J.A. Lee Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology J Gynecol Oncol 22 2011 32 38
31. S. de Sanjose, W.G. Quint, L. Alemany, D.T. Geraets, J.E. Klaustermeier, and B. Lloveras Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 2010 1048 1056
32. J. Du, A. Nasman, J.W. Carlson, T. Ramqvist, and T. Dalianis Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination Acta Oncol 50 2011 1215 1219
33. F. Coutlee, S. Ratnam, A.V. Ramanakumar, R.R. Insinga, J. Bentley, and N. Escott Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada J Med Virol 83 2011 1034 1041